Market research on the tissue and hygiene industry. Our reports feature standardised and cross-comparable total market sizes, market and brand share data, distribution and trends.
As markets emerge from the COVID-19-driven consumer environment, the disposable hygiene industry is expected to see continued growth, supported by recovery in developing markets. Industry players are responding to the need for affordable products,…
Sales of Rx/reimbursement adult incontinence struggled in sales over the review period in Germany due to social considerations, however 2020 bucked the trend due to the pandemic. Economic uncertainties coupled with more conservative behaviour of the…
According to Serbian health insurance law, there is a defined list of patients who are eligible to receive Rx/reimbursement services. There were no changes to the legislation framework which enables this service in 2020. The service includes the…
In Latvia, only medium/heavy incontinence products are reimbursed. Depending on the health disorder, there are two types of reimbursement: 50% or 100% of the total cost. The brands and products eligible for reimbursement are defined by the List of…
Rx/reimbursement adult incontinence sales slowed down a bit in light of the pandemic in both retail volume and current value terms in 2020. Majority of the attention was focused on the away-from home channel which slightly affected sales.…
The impact of COVID-19 on Rx/reimbursement adult incontinence sales in 2020 was limited. Products in this category are mainly purchased in pharmacies, which remained open throughout the crisis. The legal framework also remains unchanged, with…
The COVID-19 pandemic had no significant impact on volume or value sales of Rx/reimbursement adult incontinence in 2020. Pharmacies remained the principal channel through which consumers obtained products and these stayed open during the country’s…
Overall, wipes benefited from the COVID-19 pandemic and increased need for frequent cleaning of surfaces and hands. Essential wipes required in the household were particularly popular, including products required to clean the house, kill germs and…
A much larger category compared to retail adult incontinence in Turkey, RX/reimbursement adult incontinence recorded an upturn in demand in 2020 with concerns over potential product shortages encouraging initial stockpiling due to the pandemic, with…
Sales of Rx/reimbursement adult incontinence products grew by 5% in 2020, with COVID-19 having little impact on growth, with this figure aligning to results seen in 2019. As such, the outbreak of the virus did not adapt consumers habits surrounding…
In March 2020, at the beginning of lockdown due to the COVID-19 pandemic, users of incontinence products
Value sales of Rx/reimbursement adult incontinence grew by 5% in 2020, with the outbreak of COVID-19 creating some short-term disruptions to access, with some consumers facing difficulty accessing healthcare institutions. As a result, some members of…
Volume demand accelerated slightly in 2020 as a result of the reaction to the lockdown, with many consumers being anxious to ensure a steady supply. A lot of prescribers are elderly people needing to self-isolate more than others given the lower…
The outbreak of COVID-19 had little impact on Rx/reimbursement adult incontinence, with pharmacies remaining open throughout the pandemic. Similar to retail adult incontinence, growth in Rx/reimbursement adult incontinence was driven by a natural…
Rx/reimbursement adult incontinence saw solid volume growth during most of the review period, but turned to strong decline in 2020. However, it was not COVID-19 which negatively affected sales in this year, but local currency depreciation and…
During 2020, an increasing number of Americans turned to Medicaid, private insurance, health savings accounts and flexible spending accounts to address their elevated incontinence needs due to extended home seclusion and heightened health awareness.…
Rx/reimbursement adult incontinence continued to see a decline in volume and current value sales in 2020. The downward trajectory in the category was exacerbated by Coronavirus (COVID-19), as consumers, especially in vulnerable households, found it…
Rx/reimbursement adult incontinence recorded slightly higher value and volume growth in 2020 compared to 2019. This was most likely caused by stockpiling due to the COVID-19 pandemic, reflecting the generally vulnerable nature of consumers due to…
Rx/reimbursement adult incontinence recorded moderate volume and minimal value growth in 2020 as many consumers (temporarily) switched to rx versions of incontinence products due to the rapid increases in average retail unit prices in both 2019 and…
There was no measurable impact of COVID-19 on rx/reimbursement adult incontinence in Sweden in 2020. With these products needing to be prescribed by a medical professional, they were not impacted by stockpiling, home seclusion or preventative health…